Clinical Trials Directory

Trials / Completed

CompletedNCT01809587

IQP-PO-101 for the Regulation of Bowel Movement Frequency

Open Label Study to Assess the Safety and Efficacy of IQP-PO-101 in Regulating Bowel Movement Frequency

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
50 (actual)
Sponsor
InQpharm Group · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to evaluate the safety and efficacy of IQP-PO-101 in regulating the bowel movement frequency

Conditions

Interventions

TypeNameDescription
DEVICEIQP-PO-101

Timeline

Start date
2013-03-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2013-03-12
Last updated
2014-01-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01809587. Inclusion in this directory is not an endorsement.